GMRE Overview

CEO Purchase at Global Medical REIT: Mark Okey Decker Jr., CEO of Global Medical REIT, bought 10,000 shares at $32.51 each, totaling $325,100, and is currently up 7.3% based on recent trading highs.

Previous Investments by CEO: Decker Jr. has previously invested $1.58 million in GMRE over the past year, purchasing shares at an average price of $7.87.

Director Purchase at Insulet: Timothy C. Stonesifer, a director at Insulet, purchased 962 shares for $299,884 at $311.73 each, marking his first purchase in the last year.

Current Trading Status: Insulet shares are currently trading lower than Stonesifer's purchase price, with a recent low of $297.63, which is 4.5% below his buying price.

Quarterly Dividend Announcement: Global Medical REIT (GMRE) has declared a quarterly dividend of $0.75 per share, with a forward yield of 9.19%.

Dividend Payment Details: The dividend is payable on January 9, for shareholders of record on December 19, with an ex-dividend date also set for December 19.

Preferred Stock Offering: GMRE has priced a new preferred stock offering at $50 million, with shares priced at $25.00 each.

Market Activity: AEW Capital has exited six REITs in Q3 and initiated a position in American Tower, indicating shifts in investment strategies within the REIT sector.

Public Offering Announcement: Global Medical REIT Inc. has priced an underwritten public offering of 2,000,000 shares of its 8.00% Series B Cumulative Redeemable Preferred Stock, aiming to raise approximately $50 million before expenses, with the offering expected to close on November 20, 2025.

Use of Proceeds: The net proceeds from the offering will be utilized for general corporate purposes, which may include funding new acquisitions and repaying existing debt.

Underwriters and Listing: The offering is managed by several financial institutions, and the Company plans to list the Series B Preferred Stock on the New York Stock Exchange under the symbol "GMRE PrB."

Forward-Looking Statements: The press release includes forward-looking statements regarding the offering's closing, use of proceeds, and listing, which are subject to risks and uncertainties that could lead to different outcomes than anticipated.

Public Offering Announcement: Global Medical REIT (GMRE) has priced an underwritten public offering of 2 million shares of its 8.00% Series B Cumulative Redeemable Preferred Stock, aiming to raise approximately $50 million before expenses.

Use of Proceeds: The net proceeds from the offering will be used for general corporate purposes, including funding new acquisitions and repaying existing debt.

Closing Date: The transaction is expected to close on November 20, 2025, with underwriters granted a 30-day option to purchase an additional 300,000 shares.

Stock Exchange Listing: GMRE plans to apply for the new Series B Preferred Stock to be listed on the New York Stock Exchange under the ticker symbol "GMRE PrB."